According to Edwards Lifesciences's latest financial reports and stock price the company's current number of shares outstanding is 601,600,000. At the end of 2024 the company had 601,600,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 0.60 B | -0.89% |
2023 | 0.60 B | -0.96% |
2022 | 0.61 B | -1.79% |
2021 | 0.62 B | 0.1% |
2020 | 0.62 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Medtronic MDT | 1,329,700,000 | 121.03% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 1,468,400,000 | 144.08% | ๐บ๐ธ USA |
Merit Medical MMSI | 57,958,000 | -90.37% | ๐บ๐ธ USA |
LeMaitre Vascular LMAT | 22,365,000 | -96.28% | ๐บ๐ธ USA |
ICU Medical
ICUI | 24,222,000 | -95.97% | ๐บ๐ธ USA |
CryoLife CRY | 37,740,400 | -93.73% | ๐บ๐ธ USA |